novo nordisk oral semaglutide fda approval Nordisk's weight-loss pill wins Novo Nordisk wins FDA approval

The original studies that proved the efficacy of semaglutide for weight loss examined patients who were exercising, says Dr

Cardiovascular outcomes trials demonstrate that GLP-1 benefits extend beyond weight alonethese medications lower heart attack and stroke risk by 26% in high-risk patients

Unlike exogenous HGH, which bypasses pituitary control and may cause supraphysiologic spikes, the CJC-1295 + Ipamorelin combination stimulates the bodys natural GH secretion

The Better Business Bureau gave Henry Meds an F rating

Here is who benefits most: Good fit if you: Qualify for GLP-1 medication (BMI 30+ or BMI 27+ with a weight-related condition) Want behavioral coaching alongside medication, not just a prescription Prefer a structured program with lessons, food logging, and community support Have tried medication alone and struggled with side effects or regain Want compounded medication shipped to your door (avoiding pharmacy visits) Not a good fit if you: Want the cheapest way to get a GLP-1 prescription (Ro and similar services are less expensive for medication-only access) Already have strong nutrition habits and just need the drug Live in Alabama, Louisiana, Mississippi, or Virginia (some programs unavailable) Have a history of medullary thyroid cancer, multiple endocrine neoplasia 2, or active gastrointestinal conditions like gastroparesis Want brand-name medication but do not have insurance to cover it (the out-of-pocket drug cost makes it very expensive) How Noom Med Compares to Alternatives The GLP-1 telehealth space has gotten crowded